Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Oct. 3, 2013, 116 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $30.21 to $14,999,997.60. Highlighted Stocks Traded by Insiders: CareFusion (CFN) - FREE Research Report Leonard Thomas J who is President, Medical Systems at CareFusion sold 1,250 shares at $36.99 on Oct. 3, 2013. Following this transaction, the President, Medical Systems owned 63,549 shares meaning that the stake was reduced by 1.93% with the 1,250 share transaction. The shares most recently traded at $37.69, up $0.70, or 1.86% since the insider transaction. Historical insider transactions for CareFusion go as follows:
4-Week # shares sold: 1,250
12-Week # shares sold: 62,050
24-Week # shares sold: 62,050
The average volume for CareFusion has been 1.9 million shares per day over the past 30 days. CareFusion has a market cap of $8.0 billion and is part of the health care sector and health services industry. Shares are up 30.69% year to date as of the close of trading on Thursday. CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. The company has a P/E ratio of 21.5. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on CFN - FREETheStreet Quant Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.